,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type  ,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m
0,,,,,,,,,,,,,,,,
1,,2021-10-04 16:41:25,2021-10-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$68.67,-389,"31,263",-1%,"-$26,713",,,,
2,,2021-09-03 07:40:32,2021-09-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$76.71,-388,"31,652",-1%,"-$29,763",,,,
3,,2021-08-04 16:16:19,2021-08-02,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$77.49,-389,"32,040",-1%,"-$30,144",,,,
4,,2021-08-02 16:14:20,2021-07-29,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$78.29,"-4,911","27,005",-15%,"-$384,482",,,,
5,,2021-07-02 19:15:24,2021-07-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$84.09,-396,"26,149",-1%,"-$33,300",,,,
6,D,2021-06-14 16:28:17,2021-06-10,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$87.00,"-3,845","26,545",-13%,"-$334,515",,,,
7,,2021-06-03 16:42:35,2021-06-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$84.13,-395,"26,545",-1%,"-$33,231",,,,
8,,2021-05-05 16:09:04,2021-05-03,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$85.40,-396,"26,940",-1%,"-$33,818",,,,
9,,2021-04-05 16:25:39,2021-04-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$81.57,-396,"27,336",-1%,"-$32,302",,,,
10,,2021-03-31 16:10:24,2021-03-29,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",S - Sale,$81.08,"-20,000","45,452",-31%,"-$1,621,600",,,,
11,,2021-03-03 16:28:10,2021-03-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$79.73,-395,"27,732",-1%,"-$31,493",,,,
12,,2021-02-23 16:54:13,2021-02-23,INCY,Hoppenot Herve,"COB ,  CEO",P - Purchase,$77.37,"+12,925","350,465",+4%,"+$1,000,007",,,,
13,D,2021-02-03 16:27:38,2021-02-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$90.00,"-1,356","28,127",-5%,"-$122,040",,,,
14,D,2021-01-27 17:32:18,2021-01-25,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$100.00,"-21,545","143,784",-13%,"-$2,154,500",,,,
15,D,2021-01-27 17:09:06,2021-01-25,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$100.00,"-3,795","119,744",-3%,"-$379,500",,,,
16,D,2021-01-27 17:03:16,2021-01-25,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$99.00,"-5,116","26,158",-16%,"-$506,484",,,,
17,,2021-01-27 16:52:09,2021-01-25,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$100.00,"-2,744","49,994",-5%,"-$274,400",,,,
18,,2020-11-12 16:41:38,2020-11-10,INCY,Bienaime Jean Jacques,Dir,S - Sale,$83.00,-798,"8,646",-8%,"-$66,234",,,,
19,D,2020-11-10 16:26:54,2020-11-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$85.17,-961,"28,010",-3%,"-$81,848",,,,
20,D,2020-11-04 16:15:40,2020-11-02,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$86.60,"-20,000","39,984",-33%,"-$1,732,000",,,,
21,D,2020-10-13 17:10:55,2020-10-09,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$95.00,"-1,423","28,459",-5%,"-$135,185",,,,
22,D,2020-10-08 16:21:45,2020-10-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$91.97,-961,"28,010",-3%,"-$88,383",,,,
23,D,2020-09-14 16:19:44,2020-09-10,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$90.83,"-2,193","28,331",-7%,"-$199,190",,,,
24,D,2020-09-10 16:21:35,2020-09-08,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$88.94,-961,"28,010",-3%,"-$85,471",,,,
25,D,2020-08-31 16:26:17,2020-08-27,INCY,Dixon Wendy L,Dir,S - Sale+OE,$94.51,"-20,000","14,243",-58%,"-$1,890,200",,,,
26,D,2020-08-10 16:20:57,2020-08-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$97.80,-961,"28,010",-3%,"-$93,986",,,,
27,,2020-07-17 16:20:57,2020-07-16,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale,$103.83,-766,"95,468",-1%,"-$79,534",,,,
28,M,2020-07-08 17:31:17,2020-07-07,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$108.06,"-3,595","25,926",-12%,"-$388,464",,,,
29,DM,2020-07-08 17:27:32,2020-07-07,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$109.52,"-14,769","96,857",-13%,"-$1,617,548",,,,
30,D,2020-07-07 19:30:07,2020-07-06,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$107.32,"-16,553","156,258",-10%,"-$1,776,468",,,,
31,D,2020-07-07 19:25:52,2020-07-06,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$107.25,"-36,124","100,750",-26%,"-$3,874,171",,,,
32,D,2020-07-07 19:18:12,2020-07-07,INCY,Hoppenot Herve,"COB ,  CEO",S - Sale+OE,$110.00,"-89,771","730,139",-11%,"-$9,874,810",,,,
33,D,2020-07-07 19:13:36,2020-07-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$106.58,-961,"25,591",-4%,"-$102,423",,,,
34,D,2020-06-30 16:06:21,2020-06-26,INCY,Hoppenot Herve,"COB ,  CEO",S - Sale+OE,$102.91,"-124,148","505,539",-20%,"-$12,776,071",,,,
35,D,2020-06-25 17:15:52,2020-06-23,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$110.00,"-6,943","21,734",-24%,"-$763,730",,,,
36,D,2020-06-25 17:09:56,2020-06-23,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$110.00,-400,"36,061",-1%,"-$44,000",,,,
37,D,2020-06-23 16:42:06,2020-06-19,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$100.00,"-1,423","23,661",-6%,"-$142,300",,,,
38,D,2020-06-23 16:33:11,2020-06-19,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$105.00,"-7,866","24,901",-24%,"-$825,930",,,,
39,D,2020-06-23 16:23:03,2020-06-19,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$105.00,"-7,181","35,862",-17%,"-$754,005",,,,
40,,2020-06-23 16:17:21,2020-06-22,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",S - Sale,$105.31,"-9,000","21,762",-29%,"-$947,790",,,,
41,D,2020-06-12 16:11:15,2020-06-10,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$94.51,"-3,615","23,534",-13%,"-$341,649",,,,
42,D,2020-06-10 16:34:48,2020-06-08,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$91.87,-961,"19,987",-5%,"-$88,287",,,,
43,D,2020-05-28 20:07:51,2020-05-28,INCY,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$102.55,+2,"29,906,571",0%,+$205,,,,
44,D,2020-05-08 16:53:04,2020-05-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$96.84,-961,"19,987",-5%,"-$93,063",,,,
45,D,2020-04-21 16:35:38,2020-04-17,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$100.00,"-1,143","21,324",-5%,"-$114,300",,,,
46,D,2020-04-21 16:28:55,2020-04-17,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$100.00,"-6,583","35,342",-16%,"-$658,300",,,,
47,DM,2020-04-20 17:08:00,2020-04-16,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$97.50,"-18,976","22,899",-45%,"-$1,850,160",,,,
48,DM,2020-04-15 16:57:36,2020-04-13,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$89.78,"-18,792","22,899",-45%,"-$1,687,111",,,,
49,,2020-04-08 16:39:41,2020-04-06,INCY,Pasquale Maria E,"EVP, GC",S - Sale,$85.00,"-1,842","24,254",-7%,"-$156,570",,,,
50,D,2020-04-08 16:35:27,2020-04-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$85.00,"-3,844","19,987",-16%,"-$326,740",,,,
51,D,2020-04-02 17:32:54,2020-03-31,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$71.44,"-2,329","48,493",-5%,"-$166,384",,,,
52,D,2020-02-21 16:11:19,2020-02-19,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,"-2,500","48,493",-5%,"-$200,000",,,,
53,D,2020-02-07 16:48:00,2020-02-05,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$75.97,"-17,542","95,308",-16%,"-$1,332,666",,,,
54,D,2020-01-17 16:20:38,2020-01-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$81.12,"-2,500","41,612",-6%,"-$202,800",,,,
55,D,2019-12-18 16:59:40,2019-12-16,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$91.61,"-2,500","41,612",-6%,"-$229,025",,,,
56,DM,2019-12-03 16:32:39,2019-11-29,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$95.00,"-20,000","95,308",-17%,"-$1,900,000",,,,
57,DM,2019-12-03 16:25:53,2019-11-29,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$95.00,"-7,866","17,609",-31%,"-$747,270",,,,
58,DM,2019-12-03 16:20:46,2019-11-29,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$95.00,"-7,182","16,979",-30%,"-$682,290",,,,
59,D,2019-11-26 16:31:05,2019-11-25,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$90.00,"-2,142","16,979",-11%,"-$192,780",,,,
60,D,2019-11-26 16:11:48,2019-11-25,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$90.00,"-15,000","95,308",-14%,"-$1,350,000",,,,
61,D,2019-11-26 16:06:21,2019-11-25,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$90.00,"-15,000","17,306",-46%,"-$1,350,000",,,,
62,D,2019-11-19 17:45:30,2019-11-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$86.46,"-2,500","41,612",-6%,"-$216,150",,,,
63,DM,2019-11-08 17:25:18,2019-11-06,INCY,Dixon Wendy L,Dir,S - Sale+OE,$83.92,"-53,334","12,340",-81%,"-$4,475,774",,,,
64,D,2019-11-05 17:23:36,2019-11-01,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$85.00,"-7,960","95,308",-8%,"-$676,600",,,,
65,D,2019-11-05 16:33:10,2019-11-01,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$85.00,"-8,500","17,306",-33%,"-$722,500",,,,
66,D,2019-10-31 16:10:02,2019-10-29,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$85.00,"-2,040","95,308",-2%,"-$173,400",,,,
67,D,2019-10-31 16:07:16,2019-10-29,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$80.45,"-16,500","17,306",-49%,"-$1,327,500",,,,
68,,2019-10-31 16:00:32,2019-10-29,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$85.00,-930,"17,609",-5%,"-$79,050",,,,
69,D,2019-10-24 18:52:50,2019-10-22,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,"-2,500","41,612",-6%,"-$200,000",,,,
70,D,2019-09-19 16:34:15,2019-09-18,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,"-2,500","41,612",-6%,"-$200,000",,,,
71,,2019-09-19 16:30:24,2019-09-17,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$77.71,"-2,491","16,757",-13%,"-$193,576",,,,
72,D,2019-08-19 16:21:23,2019-08-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.96,"-2,500","41,612",-6%,"-$202,400",,,,
73,DM,2019-08-06 18:45:59,2019-08-02,INCY,Friedman Paul A,Dir,S - Sale+OE,$82.69,"-100,000","315,531",-24%,"-$8,268,766",,,,
74,M,2019-08-05 16:36:41,2019-08-01,INCY,Bienaime Jean Jacques,Dir,S - Sale,$85.07,"-1,724","7,055",-20%,"-$146,654",,,,
75,,2019-07-18 18:13:25,2019-07-17,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$79.91,-959,"19,248",-5%,"-$76,634",,,,
76,D,2019-07-16 16:48:40,2019-07-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,"-2,500","41,612",-6%,"-$200,000",,,,
77,,2019-06-25 17:46:58,2019-06-24,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale,$87.96,"-8,357","10,805",-44%,"-$735,082",,,,
78,D,2019-06-18 17:26:28,2019-06-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,"-2,500","36,513",-6%,"-$200,000",,,,
79,D,2019-04-02 16:51:36,2019-04-01,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$87.01,"-10,000","73,026",-12%,"-$870,100",,,,
80,D,2019-03-05 16:45:26,2019-03-01,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$86.68,"-10,000","36,513",-21%,"-$866,800",,,,
81,D,2019-02-05 16:36:24,2019-02-01,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$81.19,"-10,000","31,124",-24%,"-$811,900",,,,
82,,2019-01-30 16:22:52,2019-01-28,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$80.00,"-1,000","8,944",-10%,"-$80,000",,,,
83,D,2019-01-22 18:04:25,2019-01-17,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$77.61,"-15,354","34,409",-31%,"-$1,191,624",,,,
84,D,2019-01-17 16:15:32,2019-01-15,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$75.00,"-5,813","13,900",-29%,"-$435,975",,,,
85,,2019-01-10 16:11:59,2019-01-08,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$75.56,"-1,714","9,944",-15%,"-$129,510",,,,
86,D,2019-01-08 16:46:22,2019-01-07,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$75.00,"-10,000","34,409",-23%,"-$750,000",,,,
87,D,2019-01-08 16:42:00,2019-01-07,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$75.00,"-9,187","13,900",-40%,"-$689,025",,,,
88,D,2019-01-08 16:37:33,2019-01-04,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$70.00,"-30,000","31,124",-49%,"-$2,100,000",,,,
89,,2018-11-09 16:21:28,2018-11-08,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$68.77,"+1,000","6,668",+18%,"+$68,765",,,,
90,D,2018-10-05 16:30:43,2018-10-03,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$70.00,"-10,000","14,172",-41%,"-$700,000",,,,
91,D,2018-10-05 16:29:12,2018-10-03,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$70.00,"-10,000","32,324",-24%,"-$700,000",,,,
92,,2018-10-05 16:23:36,2018-10-03,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$70.00,"-1,000","12,427",-7%,"-$70,000",,,,
93,D,2018-09-06 16:30:27,2018-09-04,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$73.21,"-10,000","32,324",-24%,"-$732,100",,,,
94,D,2018-08-22 16:02:27,2018-08-21,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$70.00,"-10,000","32,324",-24%,"-$700,000",,,,
95,D,2018-07-11 16:41:34,2018-07-09,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$71.11,"-10,000","32,963",-23%,"-$711,100",,,,
96,,2018-07-11 16:39:06,2018-07-09,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$71.34,-606,"8,103",-7%,"-$43,232",,,,
97,,2018-05-03 17:05:14,2018-05-02,INCY,Hoppenot Herve,"COB ,  CEO",P - Purchase,$60.94,"+15,000","276,690",+6%,"+$914,100",,,,
98,D,2018-05-02 17:04:20,2018-04-30,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$62.43,"-80,000","33,367",-71%,"-$4,994,400",,,,
99,,2018-02-22 16:46:22,2018-02-21,INCY,Gryska David W,"EVP, CFO",S - Sale,$85.56,"-1,952","10,970",-15%,"-$167,013",,,,
100,,2018-02-22 16:23:38,2018-02-21,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$85.55,"-1,958","35,183",-5%,"-$167,507",,,,
101,D,2018-01-09 16:09:03,2018-01-05,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$98.87,"-6,760","13,992",-33%,"-$668,361",,,,
102,D,2018-01-03 16:32:04,2018-01-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$97.26,"-5,000","8,676",-37%,"-$486,300",,,,
103,,2017-12-05 16:01:25,2017-12-01,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$98.01,-696,"38,205",-2%,"-$68,215",,,,
104,,2017-11-20 16:25:24,2017-11-16,INCY,Friedman Paul A,Dir,S - Sale,$105.24,"-28,507","269,011",-10%,"-$3,000,077",,,,
105,,2017-11-03 16:01:24,2017-11-02,INCY,Gryska David W,"EVP, CFO",S - Sale,$105.63,"-3,915","13,992",-22%,"-$413,541",,,,
106,,2017-09-20 16:28:04,2017-09-18,INCY,Hoppenot Herve,"COB ,  CEO",S - Sale,$119.45,"-70,502","299,004",-19%,"-$8,421,464",,,,
107,,2017-09-15 16:11:32,2017-09-14,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$124.25,-714,"14,782",-5%,"-$88,715",,,,
108,,2017-09-08 17:06:12,2017-09-08,INCY,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$132.00,"+100,000","942,507",+12%,"+$13,200,000",,,,
109,D,2017-09-07 16:04:50,2017-09-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$138.41,"-3,000","26,706",-10%,"-$415,230",,,,
110,D,2017-09-05 16:27:01,2017-09-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$137.40,"-1,820","21,733",-8%,"-$250,068",,,,
111,D,2017-09-05 16:22:33,2017-08-31,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$140.00,"-20,000","35,067",-36%,"-$2,800,000",,,,
112,D,2017-08-31 16:13:38,2017-08-29,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$125.00,"-2,111","18,165",-10%,"-$263,875",,,,
113,D,2017-08-07 16:33:21,2017-08-04,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$125.25,"-3,000","26,706",-10%,"-$375,750",,,,
114,D,2017-08-03 16:54:36,2017-08-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$132.92,"-1,820","21,733",-8%,"-$241,914",,,,
115,D,2017-07-21 16:01:05,2017-07-20,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$131.09,"-6,485","18,165",-26%,"-$850,119",,,,
116,D,2017-07-07 17:02:00,2017-07-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$126.18,"-3,000","12,148",-20%,"-$378,540",,,,
117,D,2017-07-05 18:20:57,2017-07-03,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$126.20,"-1,820","18,216",-9%,"-$229,684",,,,
118,D,2017-07-05 16:12:24,2017-06-30,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$129.74,-599,"19,015",-3%,"-$77,714",,,,
119,D,2017-06-22 16:29:42,2017-06-20,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$125.00,"-9,883","14,648",-40%,"-$1,235,375",,,,
120,D,2017-06-14 16:50:23,2017-06-12,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$116.60,"-16,756","19,015",-47%,"-$1,953,750",,,,
121,D,2017-06-07 16:12:51,2017-06-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$132.50,"-3,000","10,950",-22%,"-$397,500",,,,
122,D,2017-06-02 16:22:52,2017-06-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$130.00,"-1,820","16,924",-10%,"-$236,600",,,,
123,,2017-06-02 16:14:57,2017-05-31,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$131.80,+500,"4,677",+12%,"+$65,900",,,,
124,,2017-05-17 16:18:08,2017-05-15,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$115.00,+500,"4,177",+14%,"+$57,500",,,,
125,,2017-05-09 16:38:07,2017-05-08,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$119.21,"-8,577","36,037",-19%,"-$1,022,464",-1,,,
126,D,2017-05-09 16:17:15,2017-05-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$121.70,"-3,000","10,950",-22%,"-$365,100",-1,,,
127,D,2017-05-02 18:01:07,2017-05-01,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$124.73,"-5,296","12,653",-30%,"-$660,564",0,-5,,
128,D,2017-05-02 17:52:21,2017-05-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$124.73,"-1,820","16,924",-10%,"-$227,009",0,-5,,
129,D,2017-05-02 17:39:28,2017-04-28,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$124.26,"-1,389","19,015",-7%,"-$172,597",0,-5,,
130,,2017-05-02 16:31:44,2017-04-28,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$124.26,+500,"3,677",+16%,"+$62,130",0,-5,,
131,,2017-04-17 16:56:33,2017-04-13,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$139.66,"+1,000","3,177",+46%,"+$139,660",0,-2,,
132,D,2017-04-11 16:24:11,2017-04-07,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$137.89,"-32,000","14,648",-69%,"-$4,412,310",+2,-7,-13,
133,D,2017-04-11 16:19:28,2017-04-10,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$140.18,"-4,043","16,785",-19%,"-$566,748",+2,-7,-13,
134,D,2017-04-11 16:14:55,2017-04-10,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$138.00,"-41,528","19,015",-69%,"-$5,730,864",+2,-7,-13,
135,,2017-04-11 16:06:52,2017-04-07,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$139.48,"+1,000","2,177",+85%,"+$139,480",+2,-7,-13,
136,D,2017-03-20 16:14:34,2017-03-17,INCY,Brooke Paul A,Dir,S - Sale+OE,$147.75,"-20,000","196,756",-9%,"-$2,955,000",-5,-6,-15,
137,DM,2017-03-20 16:10:49,2017-03-16,INCY,Friedman Paul A,Dir,S - Sale+OE,$148.72,"-50,000","297,518",-14%,"-$7,436,164",-5,-6,-15,
138,,2017-03-01 16:56:12,2017-02-27,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$131.88,"-2,008","52,262",-4%,"-$264,815",0,0,+5,
139,D,2017-02-27 16:54:47,2017-02-23,INCY,Friedman Paul A,Dir,S - Sale+OE,$120.32,"-50,000","297,518",-14%,"-$6,016,000",-1,+2,+4,
140,,2017-01-11 16:21:12,2017-01-09,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$113.55,"-11,739","52,185",-18%,"-$1,332,963",+2,0,+6,
141,D,2016-11-17 16:29:54,2016-11-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$103.26,"-10,000","29,248",-25%,"-$1,032,600",-2,+1,-3,
142,,2016-11-10 16:34:58,2016-11-09,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$109.95,"-2,715","63,924",-4%,"-$298,514",0,-4,-4,+10
143,D,2016-10-24 16:44:53,2016-10-20,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$90.00,"-10,000","29,248",-25%,"-$900,000",-1,-1,+23,+41
144,D,2016-10-11 16:37:46,2016-10-07,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale+OE,$96.40,"-11,709","66,601",-15%,"-$1,128,748",-2,-6,0,+46
145,D,2016-10-11 16:33:00,2016-10-07,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$97.00,"-24,204","11,187",-68%,"-$2,347,788",-2,-6,0,+46
146,D,2016-09-26 16:34:48,2016-09-23,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$90.00,"-20,000","29,248",-41%,"-$1,800,000",0,+6,-1,+57
147,,2016-08-02 17:09:00,2016-08-02,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$87.96,"-10,000","66,601",-13%,"-$879,600",+2,-1,-9,+36
148,D,2016-08-02 16:54:23,2016-07-29,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$90.00,"-60,000","29,248",-67%,"-$5,400,000",+2,-1,-9,+36
149,DM,2016-03-17 19:14:13,2016-03-15,INCY,Baker Julian,"Dir, 10%",P - Purchase,$63.98,"+800,000","20,423,396",+4%,"+$51,184,194",+3,+7,+23,+27
150,M,2016-02-26 16:42:36,2016-02-24,INCY,Baker Julian,"Dir, 10%",P - Purchase,$70.79,"+64,290","19,681,963",0%,"+$4,550,987",-1,-2,-8,+11
151,M,2016-02-16 20:14:20,2016-02-12,INCY,Baker Julian,"Dir, 10%",P - Purchase,$69.87,"+887,165","19,624,181",+5%,"+$61,983,797",+4,+3,-9,+14
152,M,2016-02-16 20:13:38,2016-02-11,INCY,Baker Julian,"Dir, 10%",P - Purchase,$63.53,"+2,251,427","18,824,191",+14%,"+$143,029,696",+4,+3,-9,+14
153,D,2016-01-20 16:31:32,2016-01-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$76.96,"-13,531","23,693",-36%,"-$1,041,346",-1,+2,-4,+12
154,D,2016-01-08 16:37:56,2016-01-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$101.86,"-3,937","16,926",-19%,"-$401,023",-3,-14,-25,-10
155,D,2015-12-14 16:32:46,2015-12-10,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$107.96,"-1,936","3,710",-34%,"-$209,011",+5,+4,-29,-28
156,D,2015-12-09 16:31:06,2015-12-07,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$106.18,"-3,937","16,926",-19%,"-$418,031",+2,+6,-12,-24
157,DM,2015-11-19 17:51:48,2015-11-17,INCY,Friedman Paul A,Dir,S - Sale+OE,$113.83,"-225,000","297,518",-43%,"-$25,612,109",-3,-1,-3,-33
158,D,2015-11-12 16:30:14,2015-11-10,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$104.86,"-2,222","3,710",-37%,"-$232,999",+3,+12,+2,-29
159,D,2015-11-10 20:21:59,2015-11-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$116.51,"-3,936","16,926",-19%,"-$458,583",-3,-1,-1,-36
160,D,2015-11-05 16:47:10,2015-11-03,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$124.78,"-5,786","21,371",-21%,"-$721,961",-14,-9,-7,-39
161,D,2015-10-15 16:30:52,2015-10-13,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$101.49,"-2,222","3,355",-40%,"-$225,511",-4,-5,-8,-33
162,D,2015-10-08 16:28:41,2015-10-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$122.29,"-3,937","16,926",-19%,"-$481,456",+2,+2,+12,-24
163,D,2015-09-23 16:35:50,2015-09-21,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale+OE,$124.29,"-10,000","62,865",-14%,"-$1,242,900",-4,-14,-8,-42
164,D,2015-09-18 17:07:44,2015-09-16,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$130.69,"-2,222","3,355",-40%,"-$290,393",-6,-11,-14,-47
165,,2015-09-15 16:31:40,2015-09-11,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale,$130.00,"-4,301","16,926",-20%,"-$559,130",0,-10,-24,-51
166,D,2015-09-10 16:44:21,2015-09-08,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$118.90,"-3,937","21,227",-16%,"-$468,109",+5,+5,-18,-47
167,D,2015-08-17 16:20:45,2015-08-13,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$107.69,"-2,222","3,355",-40%,"-$239,287",-1,-10,+16,-41
168,D,2015-08-10 16:29:40,2015-08-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$111.95,"-3,936","21,227",-16%,"-$440,635",0,+2,+16,-32
169,DM,2015-07-16 16:37:56,2015-07-14,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$116.70,"-12,850","21,539",-37%,"-$1,499,538",-1,-3,-8,-34
170,D,2015-07-16 16:37:25,2015-07-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$113.61,"-2,222","3,355",-40%,"-$252,441",-1,-3,-8,-34
171,D,2015-07-16 16:36:34,2015-07-15,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$120.00,"-70,217","21,227",-77%,"-$8,426,040",-1,-3,-8,-34
172,D,2015-07-08 16:52:47,2015-07-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$107.00,"-3,937","21,227",-16%,"-$421,259",+2,+11,+5,-2
173,D,2015-06-25 16:28:05,2015-06-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$108.24,"-11,691","3,521",-77%,"-$1,265,470",0,0,+4,+4
174,D,2015-06-23 16:28:35,2015-06-19,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$108.13,"-20,000","21,227",-49%,"-$2,162,600",-4,-8,+5,+4
175,D,2015-06-16 16:02:26,2015-06-12,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$105.31,"-2,223","3,355",-40%,"-$234,104",+1,+5,+11,+2
176,D,2015-06-10 16:43:35,2015-06-08,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$107.58,"-3,937","21,227",-16%,"-$423,542",+1,-1,+2,+2
177,DM,2015-05-28 16:32:32,2015-05-26,INCY,Friedman Paul A,Dir,S - Sale+OE,$107.23,"-196,751","297,518",-40%,"-$21,096,678",+2,+1,-3,+4
178,D,2015-05-28 16:31:54,2015-05-26,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$106.40,"-12,093","3,521",-77%,"-$1,286,636",+2,+1,-3,+4
179,DM,2015-05-26 16:57:50,2015-05-21,INCY,Friedman Paul A,Dir,S - Sale+OE,$108.22,"-102,243","297,518",-26%,"-$11,064,921",+1,+2,+2,+8
180,D,2015-05-15 16:08:11,2015-05-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$104.99,"-2,222","3,355",-40%,"-$233,288",+1,+1,-3,-1
181,D,2015-05-08 16:02:43,2015-05-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$99.43,"-7,412","21,227",-26%,"-$736,975",+1,+3,+3,+13
182,D,2015-04-24 16:20:49,2015-04-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$107.67,"-36,941","3,521",-91%,"-$3,977,437",-6,-9,0,0
183,,2015-04-21 16:58:46,2015-04-17,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale,$102.04,"-7,150","21,539",-25%,"-$729,586",-1,-7,-1,-1
184,D,2015-04-16 16:29:37,2015-04-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$98.72,"-2,222","3,355",-40%,"-$219,356",-1,+5,+4,-2
185,D,2015-04-14 16:15:39,2015-04-13,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$96.29,"-16,469","21,083",-44%,"-$1,585,800",+1,+7,+6,+6
186,DM,2015-04-14 16:14:48,2015-04-10,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$95.18,"-23,000","28,689",-44%,"-$2,189,250",+1,+7,+6,+6
187,D,2015-04-08 16:18:12,2015-04-07,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$90.13,"-20,031","28,689",-41%,"-$1,805,439",+1,+8,+10,+33
188,D,2015-04-08 16:17:36,2015-04-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$88.77,"-25,000","21,227",-54%,"-$2,219,250",+1,+8,+10,+33
189,D,2015-04-01 16:27:38,2015-03-30,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$93.64,"-113,776","2,905",-98%,"-$10,653,985",-1,+2,+8,+11
190,D,2015-04-01 16:26:37,2015-03-30,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale+OE,$93.66,"-34,263","44,408",-44%,"-$3,209,206",-1,+2,+8,+11
191,D,2015-03-18 16:33:34,2015-03-16,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$89.97,"-17,500","21,083",-45%,"-$1,574,475",+5,+1,+11,+42
192,D,2015-03-13 16:28:02,2015-03-12,INCY,Ariko Barry A,Dir,S - Sale+OE,$89.27,"-80,000","45,834",-64%,"-$7,141,600",+2,+9,+12,+39
193,D,2015-03-13 16:27:18,2015-03-12,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$89.72,"-2,222","3,355",-40%,"-$199,347",+2,+9,+12,+39
194,D,2015-03-10 17:13:04,2015-03-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$89.91,"-25,000","21,227",-54%,"-$2,247,750",+1,+2,+3,+30
195,D,2015-03-09 16:37:29,2015-03-05,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$90.00,"-13,333","3,355",-80%,"-$1,199,970",0,0,0,+29
196,D,2015-03-09 16:35:21,2015-03-05,INCY,De Schutter Richard U,Chairman,S - Sale+OE,$92.09,"-40,000","92,290",-30%,"-$3,683,759",0,0,0,+29
197,D,2015-02-25 17:29:55,2015-02-25,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$85.00,"-13,333","3,355",-80%,"-$1,133,305",+2,+3,+6,+14
198,DM,2015-02-25 17:29:18,2015-02-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$82.19,"-11,112","3,521",-76%,"-$913,268",+2,+3,+6,+14
199,D,2015-02-20 16:43:54,2015-02-18,INCY,Ariko Barry A,Dir,S - Sale+OE,$78.43,"-20,000","45,834",-30%,"-$1,568,600",+1,+6,+16,+37
200,,2015-02-18 17:49:41,2015-02-13,INCY,Friedman Paul A,Dir,S - Sale,$74.32,"-120,000","297,518",-29%,"-$8,918,400",+1,+3,+17,+46
201,D,2015-02-18 17:49:03,2015-02-17,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$76.90,"-12,000","18,205",-40%,"-$922,800",+1,+3,+17,+46
202,D,2015-02-18 17:47:57,2015-02-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$76.90,"-17,500","21,083",-45%,"-$1,345,750",+1,+3,+17,+46
203,D,2015-02-10 16:33:58,2015-02-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$75.11,"-25,000","18,205",-58%,"-$1,877,750",-1,+2,+18,+36
204,D,2015-01-26 16:57:42,2015-01-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$77.68,"-11,109","3,521",-76%,"-$862,947",0,-4,-2,+32
205,DM,2015-01-26 16:57:19,2015-01-22,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$79.85,"-13,542","3,355",-80%,"-$1,081,266",0,-4,-2,+32
206,D,2015-01-20 17:28:03,2015-01-20,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$74.17,"-17,500","21,083",-45%,"-$1,297,975",0,+7,+2,+52
207,D,2015-01-20 17:27:25,2015-01-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$73.07,"-12,000","18,205",-40%,"-$876,840",0,+7,+2,+52
208,D,2015-01-12 17:06:26,2015-01-08,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$75.00,"-15,626","3,355",-82%,"-$1,171,950",+4,+2,+4,+55
209,D,2015-01-08 17:34:26,2015-01-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$71.84,"-25,000","18,205",-58%,"-$1,796,000",-2,+3,+3,+47
210,D,2015-01-07 16:29:30,2015-01-05,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$73.90,"-17,500","18,061",-49%,"-$1,293,250",-2,+2,+1,+44
211,D,2014-12-29 16:05:48,2014-12-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$74.43,"-11,113",0,-100%,"-$827,141",-2,0,+10,+36
212,D,2014-12-18 16:17:36,2014-12-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$72.36,"-12,000","18,205",-40%,"-$868,320",0,-7,0,+41
213,M,2014-12-03 16:33:52,2014-12-01,INCY,De Schutter Richard U,Chairman,S - Sale,$74.89,"-50,000","105,000",-32%,"-$3,744,358",-1,+6,-1,+43
214,D,2014-11-26 16:13:45,2014-11-24,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$74.08,"-11,111",0,-100%,"-$823,103",+1,0,-2,+48
215,D,2014-11-19 16:49:57,2014-11-17,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$69.97,"-12,000","18,205",-40%,"-$839,640",0,+3,+8,+53
216,D,2014-11-07 17:08:01,2014-11-06,INCY,Friedman Paul A,Dir,S - Sale+OE,$67.87,"-185,653","417,518",-31%,"-$12,600,269",+2,+3,+12,+52
217,D,2014-10-24 16:14:10,2014-10-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$53.49,"-11,111",0,-100%,"-$594,327",+4,+17,+31,+84
218,D,2014-10-20 16:10:50,2014-10-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$49.03,"-8,000","4,301",-65%,"-$392,240",+3,+9,+38,+117
219,D,2014-09-25 16:14:36,2014-09-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$47.65,"-11,111",0,-100%,"-$529,439",+2,-2,+13,+82
220,D,2014-09-18 16:11:14,2014-09-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$47.58,"-8,000","4,301",-65%,"-$380,640",+1,+1,+5,+100
221,D,2014-08-27 16:25:58,2014-08-25,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$51.96,"-11,111",0,-100%,"-$577,328",-1,-4,-11,+59
222,D,2014-08-19 17:43:05,2014-08-18,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$51.97,"-8,000","4,301",-65%,"-$415,760",-1,+2,-7,+52
223,D,2014-07-25 17:51:43,2014-07-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$48.54,"-11,111",0,-100%,"-$539,328",0,+1,+7,+68
224,D,2014-07-18 17:11:17,2014-07-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$48.15,"-8,000","4,301",-65%,"-$385,200",+1,+1,+9,+56
225,D,2014-06-25 16:03:25,2014-06-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$56.04,"-11,111",0,-100%,"-$622,605",0,+1,-15,+35
226,D,2014-06-18 16:02:33,2014-06-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$53.88,"-8,000","4,301",-65%,"-$431,040",-1,-1,-20,+29
227,DM,2014-06-06 18:47:53,2014-06-04,INCY,Hastings David C,CFO,S - Sale+OE,$52.73,"-200,000","8,500",-96%,"-$10,546,793",+3,+2,+3,+42
228,D,2014-05-28 16:25:08,2014-05-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$48.48,"-11,111",0,-100%,"-$538,661",+1,+4,+15,+47
229,D,2014-05-20 16:09:21,2014-05-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$50.68,"-8,000","4,301",-65%,"-$405,440",-3,+1,+15,+42
230,,2014-05-14 16:35:21,2014-05-12,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$54.00,"-2,058","1,753",-54%,"-$111,132",-9,-13,-5,+28
231,D,2014-05-06 16:11:00,2014-05-02,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$51.55,"-34,000","3,811",-90%,"-$1,752,700",-3,+2,-2,+26
232,D,2014-04-25 16:07:45,2014-04-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$47.71,"-30,555",0,-100%,"-$1,457,779",-1,+10,+4,+15
233,D,2014-02-21 17:09:41,2014-02-20,INCY,Friedman Paul A,Dir,S - Sale+OE,$63.51,"-33,354","417,518",-7%,"-$2,118,313",+3,+1,-9,-21
234,DM,2014-02-19 17:39:37,2014-02-18,INCY,De Schutter Richard U,Chairman,S - Sale+OE,$65.53,"-50,000","155,000",-24%,"-$3,276,702",+4,+10,+5,-15
235,DM,2014-02-19 17:39:21,2014-02-14,INCY,Friedman Paul A,Dir,S - Sale+OE,$65.65,"-771,182","417,518",-65%,"-$50,626,827",+4,+10,+5,-15
236,D,2014-02-18 18:05:01,2014-02-13,INCY,Ariko Barry A,Dir,S - Sale+OE,$66.49,"-10,000","45,834",-18%,"-$664,900",-6,+2,-1,-22
237,D,2014-02-18 18:04:45,2014-02-13,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$66.73,"-216,967","18,061",-92%,"-$14,478,208",-6,+2,-1,-22
238,D,2014-02-18 18:04:16,2014-02-13,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$66.67,"-56,042",0,-100%,"-$3,736,118",-6,+2,-1,-22
239,D,2014-02-18 18:03:53,2014-02-13,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$66.28,"-98,334","3,193",-97%,"-$6,517,578",-6,+2,-1,-22
240,DM,2014-02-18 18:03:30,2014-02-13,INCY,Hastings David C,CFO,S - Sale+OE,$65.86,"-275,000","8,500",-97%,"-$18,112,440",-6,+2,-1,-22
241,DM,2014-02-18 18:02:51,2014-02-13,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$66.34,"-231,096","4,301",-98%,"-$15,330,206",-6,+2,-1,-22
242,D,2014-02-18 18:02:27,2014-02-13,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$66.49,"-158,331",0,-100%,"-$10,527,428",-6,+2,-1,-22
243,,2013-11-20 16:28:43,2013-11-18,INCY,Whitfield Roy A,Dir,S - Sale,$47.37,"-50,000","621,082",-7%,"-$2,368,500",+2,+2,+7,+3
244,D,2013-09-12 16:29:27,2013-09-10,INCY,Friedman Paul A,CEO,S - Sale+OE,$37.32,"-376,789","391,868",-49%,"-$14,061,765",-2,-3,0,+70
245,DM,2013-09-09 16:14:04,2013-09-05,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$37.31,"-44,834","2,023",-96%,"-$1,672,908",-2,-3,+2,+72
246,D,2013-09-09 16:13:51,2013-09-05,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$35.06,"-94,444","18,061",-84%,"-$3,311,207",-2,-3,+2,+72
247,D,2013-09-09 16:13:40,2013-09-06,INCY,Hastings David C,CFO,S - Sale+OE,$35.16,"-100,000","8,500",-92%,"-$3,516,000",-2,-3,+2,+72
248,D,2013-09-09 16:13:28,2013-09-06,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$35.17,"-55,978",899,-98%,"-$1,968,746",-2,-3,+2,+72
249,D,2013-09-09 16:13:13,2013-09-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$35.28,"-25,000",0,-100%,"-$882,000",-2,-3,+2,+72
250,,2013-08-20 17:53:50,2013-08-19,INCY,Whitfield Roy A,Dir,S - Sale,$26.70,"-50,000","671,082",-7%,"-$1,335,000",+33,+36,+35,+131
251,,2013-05-21 16:33:58,2013-05-17,INCY,Whitfield Roy A,Dir,S - Sale,$23.08,"-40,000","721,082",-5%,"-$923,200",0,+6,-8,+109
252,D,2013-05-15 16:17:12,2013-05-13,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$22.30,"-55,699","4,301",-93%,"-$1,242,088",-3,-6,-9,+64
253,,2013-03-18 16:33:52,2013-03-14,INCY,Whitfield Roy A,Dir,S - Sale,$25.08,"-10,000","761,082",-1%,"-$250,800",-6,-6,-12,+50
254,,2013-03-05 16:13:29,2013-03-01,INCY,Whitfield Roy A,Dir,S - Sale,$22.56,"-10,000","771,082",-1%,"-$225,600",+2,+3,-3,+50
255,D,2013-03-01 16:20:23,2013-02-28,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$22.16,"-50,000",280,-99%,"-$1,108,000",+1,+3,+2,+56
256,D,2013-02-22 16:06:18,2013-02-20,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$21.53,"-103,283","18,061",-85%,"-$2,223,683",-1,+6,+7,+71
257,D,2013-02-20 16:33:54,2013-02-15,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$22.48,"-98,440",0,-100%,"-$2,212,931",-1,-1,+8,+24
258,D,2013-02-20 16:33:36,2013-02-15,INCY,Hastings David C,CFO,S - Sale+OE,$22.52,"-100,000","8,500",-92%,"-$2,252,000",-1,-1,+8,+24
259,,2013-02-20 16:33:31,2013-02-19,INCY,Whitfield Roy A,Dir,S - Sale,$21.82,"-30,000","781,082",-4%,"-$654,600",-1,-1,+8,+24
260,,2012-12-19 17:05:13,2012-12-17,INCY,De Schutter Richard U,Chairman,P - Purchase,$16.11,"+45,000","197,710",+29%,"+$724,950",+4,-1,+19,+21
261,,2012-12-19 17:05:13,2012-12-17,INCY,De Schutter Richard U,Chairman,S - Sale,$16.03,"-50,000","197,710",-20%,"-$801,500",+4,-1,+19,+21
262,D,2012-07-06 16:08:17,2012-07-05,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$25.11,"-35,700","3,034",-92%,"-$896,405",+2,+1,-27,-30
263,D,2012-07-03 18:21:09,2012-07-02,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$24.15,"-36,666","3,034",-92%,"-$885,484",+2,+4,+1,-30
264,,2012-05-25 16:13:47,2012-05-24,INCY,Whitfield Roy A,Dir,S - Sale,$22.27,"-20,000","821,082",-2%,"-$445,400",0,-8,+2,-20
265,D,2012-05-18 16:04:59,2012-05-16,INCY,Brooke Paul A,Dir,S - Sale+OE,$23.55,"-5,000","100,000",-5%,"-$117,750",+7,+4,+5,-22
266,D,2012-05-15 17:13:11,2012-05-11,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$23.22,"-147,389","18,061",-89%,"-$3,422,373",+4,+2,-6,-25
267,D,2012-05-15 17:12:18,2012-05-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$23.12,"-57,481",0,-100%,"-$1,328,954",+4,+2,-6,-25
268,D,2012-05-08 17:14:46,2012-05-07,INCY,Friedman Paul A,CEO,S - Sale+OE,$22.56,"-225,000","309,707",-42%,"-$5,076,000",-1,+2,+3,-22
269,,2012-05-01 17:10:07,2012-05-01,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$22.70,"-13,976","1,029",-93%,"-$317,255",+2,0,-2,-28
270,D,2012-05-01 17:09:24,2012-04-27,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$22.95,"-30,000",0,-100%,"-$688,500",+2,0,-2,-28
271,,2012-02-21 16:22:33,2012-02-17,INCY,Whitfield Roy A,Dir,S - Sale,$17.53,"-20,000","793,082",-2%,"-$350,656",0,-1,+7,+12
272,M,2012-01-20 16:47:56,2012-01-18,INCY,Brooke Paul A,Dir,P - Purchase,$17.70,"+50,000","150,000",+50%,"+$884,750",+1,+5,+2,+44
273,M,2012-01-17 20:43:42,2012-01-12,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$16.37,"+14,625","355,839",+4%,"+$239,408",+4,+3,+8,+51
274,M,2012-01-17 20:43:02,2012-01-12,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$16.37,"+543,239","12,430,783",+5%,"+$8,892,707",+4,+3,+8,+51
275,M,2011-12-12 17:23:17,2011-12-08,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.37,"+403,521","11,887,544",+4%,"+$5,394,595",-5,-4,+14,+56
276,M,2011-12-12 17:22:31,2011-12-08,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.37,"+10,827","341,214",+3%,"+$144,744",-5,-4,+14,+56
277,M,2011-12-07 17:58:20,2011-12-05,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.75,"+41,620","330,387",+14%,"+$572,097",+1,+2,+22,+73
278,M,2011-12-07 17:57:13,2011-12-05,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.75,"+1,555,134","11,484,023",+16%,"+$21,376,451",+1,+2,+22,+73
279,M,2011-12-01 16:33:01,2011-11-29,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.04,"+51,270","288,767",+22%,"+$668,776",-1,-8,+4,+44
280,M,2011-12-01 16:31:37,2011-11-29,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.13,"+2,406,179","9,928,889",+32%,"+$31,588,304",-1,-8,+4,+44
281,,2011-11-21 16:05:12,2011-11-17,INCY,Dixon Wendy L,Dir,P - Purchase,$13.40,"+7,500","7,500",New,"+$100,497",+2,+1,+19,+88
282,D,2011-06-23 16:31:49,2011-06-21,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$18.61,"-40,000","13,976",-74%,"-$744,395",0,+3,+6,-22
283,M,2011-06-17 16:20:08,2011-06-16,INCY,Whitfield Roy A,Dir,S - Sale,$18.02,"-20,000","813,082",-2%,"-$360,450",+2,+3,+8,-27
284,D,2011-06-10 17:06:13,2011-06-09,INCY,Hastings David C,CFO,S - Sale+OE,$17.74,"-100,000","8,500",-92%,"-$1,773,500",-1,+1,+11,-24
285,D,2011-05-19 16:17:45,2011-05-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$19.30,"-75,000","18,061",-81%,"-$1,447,636",0,-5,-5,-33
286,M,2011-05-13 16:35:31,2011-05-11,INCY,Whitfield Roy A,Dir,S - Sale,$20.16,"-20,000","833,082",-2%,"-$403,115",0,-4,-11,-34
287,DM,2011-05-11 16:17:53,2011-05-09,INCY,Schreck Patricia A,"EVP, GC",S - Sale+OE,$20.24,"-100,000","4,500",-96%,"-$2,024,100",+3,-3,-9,-33
288,M,2011-05-09 16:13:46,2011-05-05,INCY,Whitfield Roy A,Dir,S - Sale,$19.51,"-20,000","853,082",-2%,"-$390,215",+3,-2,-16,-34
289,,2011-05-09 16:13:16,2011-05-06,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$19.55,"-5,343","13,976",-28%,"-$104,456",+3,-2,-16,-34
290,D,2011-04-13 16:09:01,2011-04-11,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,S - Sale+OE,$17.41,"-100,000","66,504",-60%,"-$1,741,000",0,-2,+17,-7
291,D,2011-04-08 16:19:10,2011-04-07,INCY,Schreck Patricia A,"EVP, GC",S - Sale+OE,$16.50,"-100,000","4,500",-96%,"-$1,650,000",+1,+2,+18,-7
292,D,2011-04-08 16:18:48,2011-04-08,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$17.01,"-25,000","11,319",-69%,"-$425,126",+1,+2,+18,-7
293,,2011-04-07 16:17:33,2011-04-05,INCY,Whitfield Roy A,Dir,S - Sale,$16.01,"-10,000","873,082",-1%,"-$160,147",+5,+6,+20,-8
294,,2011-03-25 17:13:02,2011-03-25,INCY,Whitfield Roy A,Dir,S - Sale,$14.65,"-10,000","883,082",-1%,"-$146,528",+1,+9,+19,-9
295,DM,2011-03-18 16:13:17,2011-03-16,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,S - Sale+OE,$14.26,"-210,000","66,504",-76%,"-$2,995,427",-2,+3,+26,+5
296,D,2011-02-22 16:18:05,2011-02-17,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,S - Sale+OE,$14.35,"-50,000","66,504",-43%,"-$717,500",-2,0,+2,+5
297,D,2011-01-20 16:16:02,2011-01-18,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$15.80,"-40,310",0,-100%,"-$636,847",-3,-1,-7,+27
298,M,2010-12-23 16:05:57,2010-12-22,INCY,Whitfield Roy A,Dir,S - Sale,$17.01,"-20,000","896,082",-2%,"-$340,228",-1,-1,-15,+9
299,M,2010-11-18 16:07:25,2010-11-16,INCY,Whitfield Roy A,Dir,S - Sale,$15.99,"-11,000","916,082",-1%,"-$175,942",0,-1,-2,+23
300,M,2010-10-26 16:53:48,2010-10-22,INCY,Whitfield Roy A,Dir,S - Sale,$16.97,"-34,253","927,082",-4%,"-$581,251",+1,-1,-11,+6
301,M,2010-09-23 17:49:01,2010-09-21,INCY,"14159 Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,"-32,152","237,497",-12%,"-$478,320",+2,+7,+12,-5
302,M,2010-09-23 17:47:41,2010-09-21,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,"-397,050","2,933,021",-12%,"-$5,906,851",+2,+7,+12,-5
303,M,2010-09-23 17:46:25,2010-09-21,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,"-32,388","239,258",-12%,"-$481,831",+2,+7,+12,-5
304,M,2010-09-23 17:43:42,2010-09-21,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,"-21,623","159,739",-12%,"-$321,682",+2,+7,+12,-5
305,M,2010-09-23 17:39:05,2010-09-21,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,"-1,016,787","7,511,046",-12%,"-$15,126,583",+2,+7,+12,-5
306,M,2010-08-11 17:31:39,2010-08-09,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,"-12,803","271,646",-5%,"-$180,074",-1,-1,+4,+13
307,M,2010-08-11 17:24:56,2010-08-09,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,"-8,547","181,362",-5%,"-$120,214",-1,-1,+4,+13
308,M,2010-08-11 17:22:56,2010-08-09,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,"-156,929","3,330,071",-5%,"-$2,207,205",-1,-1,+4,+13
309,M,2010-08-11 17:21:05,2010-08-09,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,"-401,872","8,527,833",-5%,"-$5,652,328",-1,-1,+4,+13
310,M,2010-08-11 17:18:57,2010-08-09,INCY,"14159 Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,"-12,705","269,649",-4%,"-$178,696",-1,-1,+4,+13
311,D,2010-08-10 16:09:21,2010-08-06,INCY,Schreck Patricia A,"EVP, GC",S - Sale+OE,$13.88,"-94,960","4,500",-95%,"-$1,318,250",-4,-5,0,+8
312,,2010-08-10 16:08:44,2010-08-09,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$14.06,"-15,618","5,343",-75%,"-$219,535",-4,-5,0,+8
313,,2010-07-06 07:51:08,2010-07-01,INCY,Hastings David C,CFO,P - Purchase,$10.24,"+2,000","8,500",+31%,"+$20,480",0,+9,+25,+54
314,,2010-07-06 07:50:53,2010-07-01,INCY,Friedman Paul A,CEO,P - Purchase,$10.43,"+10,000","264,565",+4%,"+$104,257",0,+9,+25,+54
315,D,2010-06-21 16:10:33,2010-06-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$13.15,"-97,917",0,-100%,"-$1,287,609",-7,-5,-6,+19
316,D,2010-03-17 16:41:52,2010-03-15,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$12.94,"-20,000",0,-100%,"-$258,800",-2,+6,+6,+4
317,,2010-01-08 16:29:36,2010-01-08,INCY,Friedman Steven M.,"EVP, Biology, Preclinical Dev",S - Sale,$10.90,"-22,000","38,137",-37%,"-$239,800",+1,-7,-9,+10
318,M,2009-03-10 16:33:24,2009-03-06,INCY,Friedman Paul A,CEO,P - Purchase,$2.10,"+20,000","254,565",+9%,"+$42,000",-8,-3,-2,+228
319,DM,2009-03-05 18:16:06,2009-03-03,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,+162,"139,615",0%,+$348,0,-3,+10,+178
320,DM,2009-03-05 18:03:28,2009-03-03,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,"+3,447","3,487,000",0%,"+$7,402",0,-3,+10,+178
321,DM,2009-03-05 17:51:29,2009-03-03,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,+10,"284,449",0%,+$21,0,-3,+10,+178
322,DM,2009-03-05 17:31:53,2009-03-03,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,"+20,756","7,081,505",0%,"+$44,630",0,-3,+10,+178
323,DM,2009-03-05 17:19:24,2009-03-03,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,+576,"180,848",0%,"+$1,239",0,-3,+10,+178
324,M,2009-03-05 16:41:12,2009-03-03,INCY,Friedman Paul A,CEO,P - Purchase,$2.20,"+20,000","234,565",+9%,"+$44,000",0,-3,+10,+178
325,D,2009-03-02 20:05:46,2009-03-02,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,+17,"284,439",0%,+$37,-3,-6,-2,+179
326,D,2009-03-02 19:34:02,2009-03-02,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,+343,"139,453",0%,+$738,-3,-6,-2,+179
327,D,2009-03-02 18:40:28,2009-03-02,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,"+7,701","3,483,553",0%,"+$16,580",-3,-6,-2,+179
328,AD,2009-03-02 18:24:00,2009-03-02,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,+927,"180,272",+1%,"+$1,996",-3,-6,-2,+179
329,AD,2009-03-02 18:07:14,2009-03-02,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,"+33,364","7,060,749",0%,"+$71,831",-3,-6,-2,+179
330,D,2009-03-02 16:49:11,2009-03-02,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,+927,"180,272",+1%,"+$1,996",-3,-6,-2,+179
331,D,2009-03-02 16:40:30,2009-03-02,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,"+33,364","7,060,749",0%,"+$71,831",-3,-6,-2,+179
332,ADM,2008-12-22 20:50:34,2008-12-17,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.50,"+227,282","3,475,852",+7%,"+$796,590",-1,-7,-14,-8
333,ADM,2008-12-22 20:48:02,2008-12-17,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.49,+839,"284,422",0%,"+$2,930",-1,-7,-14,-8
334,ADM,2008-12-22 20:47:09,2008-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+20,088","344,663",+6%,"+$70,422",-1,-7,-14,-8
335,ADM,2008-12-22 20:46:03,2008-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+735,417","7,027,385",+12%,"+$2,578,159",-1,-7,-14,-8
336,ADM,2008-12-22 20:38:42,2008-12-17,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+5,056","139,110",+4%,"+$17,730",-1,-7,-14,-8
337,DM,2008-12-19 19:24:26,2008-12-17,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.50,"+227,270","3,475,840",+7%,"+$796,551",-5,-5,-10,-14
338,DM,2008-12-19 19:12:17,2008-12-17,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.55,"+1,896","285,479",+1%,"+$6,734",-5,-5,-10,-14
339,DM,2008-12-19 18:52:27,2008-12-17,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+5,056","139,110",+4%,"+$17,730",-5,-5,-10,-14
340,ADM,2008-12-19 18:44:31,2008-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+20,085","344,660",+6%,"+$70,412",-5,-5,-10,-14
341,ADM,2008-12-19 18:42:56,2008-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+735,332","7,027,300",+12%,"+$2,577,883",-5,-5,-10,-14
342,DM,2008-12-19 18:38:25,2008-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+735,332","7,027,300",+12%,"+$2,577,883",-5,-5,-10,-14
343,DM,2008-12-19 18:08:56,2008-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,"+20,085","344,660",+6%,"+$70,412",-5,-5,-10,-14
344,,2008-11-24 07:53:15,2008-11-21,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,P - Purchase,$2.19,"+5,000","49,839",+11%,"+$10,950",+4,+4,+23,+5
345,,2008-11-21 08:03:08,2008-11-20,INCY,Chardonnet Laurent,Vice President and Treasurer,P - Purchase,$2.71,"+8,000","8,250",>999%,"+$21,677",+13,+34,+41,+18
346,,2008-11-21 08:02:53,2008-11-20,INCY,Hastings David C,CFO,P - Purchase,$2.36,"+4,000","6,500",+160%,"+$9,440",+13,+34,+41,+18
347,,2008-11-21 08:02:39,2008-11-20,INCY,Schreck Patricia A,"EVP, GC",P - Purchase,$2.44,"+2,500","4,500",+125%,"+$6,100",+13,+34,+41,+18
348,,2008-11-21 08:02:24,2008-11-20,INCY,Friedman Paul A,CEO,P - Purchase,$2.55,"+13,000","214,565",+6%,"+$33,147",+13,+34,+41,+18
349,M,2008-10-16 16:28:21,2008-10-14,INCY,Friedman Paul A,CEO,P - Purchase,$4.95,"+10,000","201,565",+5%,"+$49,506",-2,+9,-19,-63
350,,2008-08-05 09:29:36,2008-07-31,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,"+201,648","3,248,570",+7%,"+$1,814,832",0,+2,+1,-67
351,,2008-08-05 09:17:37,2008-07-31,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,"+1,539","283,583",+1%,"+$13,851",0,+2,+1,-67
352,,2008-08-05 09:16:02,2008-07-31,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,"+864,092","6,291,968",+16%,"+$7,776,828",0,+2,+1,-67
353,,2008-08-05 09:15:06,2008-07-31,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,"+27,724","159,257",+21%,"+$249,516",0,+2,+1,-67
354,,2008-08-05 09:09:41,2008-07-31,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,"+4,997","134,054",+4%,"+$44,973",0,+2,+1,-67
355,,2008-01-24 17:04:12,2008-01-22,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,+7,"131,533",0%,+$74,-2,+5,-14,-21
356,,2008-01-24 17:03:13,2008-01-22,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,+223,"5,427,876",0%,"+$2,368",-2,+5,-14,-21
357,,2008-01-24 17:01:45,2008-01-22,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,+65,"3,046,922",0%,+$690,-2,+5,-14,-21
358,,2008-01-24 17:00:43,2008-01-22,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,+4,"129,057",0%,+$42,-2,+5,-14,-21
359,,2008-01-24 16:59:48,2008-01-22,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,+1,"282,044",0%,+$11,-2,+5,-14,-21
360,,2008-01-16 16:46:39,2008-01-14,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,+94,"282,043",0%,"+$1,033",+4,+1,+8,-22
361,,2008-01-16 16:45:39,2008-01-14,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,"+34,621","5,427,653",+1%,"+$380,398",+4,+1,+8,-22
362,,2008-01-16 16:44:39,2008-01-14,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,"+1,101","131,526",+1%,"+$12,097",+4,+1,+8,-22
363,,2008-01-16 16:43:46,2008-01-14,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,"+13,675","3,046,857",0%,"+$150,254",+4,+1,+8,-22
364,,2008-01-16 16:42:10,2008-01-14,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,+723,"129,053",+1%,"+$7,944",+4,+1,+8,-22
365,M,2008-01-11 16:46:47,2008-01-09,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,+334,"281,949",0%,"+$3,655",+5,+10,+7,-24
366,M,2008-01-11 16:44:17,2008-01-09,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,"+48,393","3,033,182",+2%,"+$529,507",+5,+10,+7,-24
367,M,2008-01-11 16:43:20,2008-01-09,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,"+122,514","5,393,032",+2%,"+$1,340,524",+5,+10,+7,-24
368,M,2008-01-11 16:41:47,2008-01-09,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,"+3,891","259,877",+2%,"+$42,575",+5,+10,+7,-24
369,M,2008-01-11 16:39:47,2008-01-09,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,"+2,559","128,330",+2%,"+$28,000",+5,+10,+7,-24
370,M,2008-01-08 17:39:03,2008-01-04,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,"+993,832","5,270,518",+23%,"+$10,078,734",-3,0,+1,-40
371,M,2008-01-08 17:35:03,2008-01-04,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,"+31,573","252,300",+14%,"+$320,189",-3,0,+1,-40
372,M,2008-01-08 17:32:33,2008-01-04,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,"+392,571","2,984,789",+15%,"+$3,981,175",-3,0,+1,-40
373,M,2008-01-08 17:28:09,2008-01-04,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,"+20,749","125,771",+20%,"+$210,422",-3,0,+1,-40
374,M,2008-01-08 17:22:05,2008-01-04,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,"+2,712","281,615",+1%,"+$27,504",-3,0,+1,-40
375,M,2007-12-19 17:44:49,2007-12-17,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,"+4,960","105,022",+5%,"+$52,563",+1,-1,+7,-18
376,M,2007-12-19 17:41:53,2007-12-17,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,+648,"278,903",0%,"+$6,867",+1,-1,+7,-18
377,M,2007-12-19 17:39:18,2007-12-17,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,"+93,849","2,592,218",+4%,"+$994,552",+1,-1,+7,-18
378,M,2007-12-19 17:33:53,2007-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,"+237,587","4,276,686",+6%,"+$2,517,796",+1,-1,+7,-18
379,M,2007-12-19 17:30:49,2007-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,"+7,549","187,088",+4%,"+$80,000",+1,-1,+7,-18
380,M,2007-12-12 17:11:41,2007-12-10,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,"+433,415","4,039,099",+12%,"+$4,329,179",+3,+2,+4,-19
381,M,2007-12-12 17:08:37,2007-12-10,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,"+13,769","169,406",+9%,"+$137,533",+3,+2,+4,-19
382,M,2007-12-12 17:07:12,2007-12-10,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,"+1,183","278,255",0%,"+$11,816",+3,+2,+4,-19
383,AM,2007-12-12 16:56:41,2007-12-10,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,"+9,049","100,062",+10%,"+$90,386",+3,+2,+4,-19
384,AM,2007-12-12 16:54:37,2007-12-10,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,"+171,202","2,498,369",+7%,"+$1,710,056",+3,+2,+4,-19
385,M,2007-12-12 16:45:08,2007-12-10,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$9.99,"+171,202","2,498,369",+7%,"+$1,710,056",+3,+2,+4,-19
386,M,2007-12-12 16:38:43,2007-12-10,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$9.99,"+9,049","100,062",+10%,"+$90,386",+3,+2,+4,-19
387,,2007-12-06 17:12:02,2007-12-04,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.98,"+1,139","91,013",+1%,"+$10,230",-5,+8,-3,-13
388,,2007-12-06 17:10:07,2007-12-04,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.98,"+19,593","2,327,167",+1%,"+$175,980",-5,+8,-3,-13
389,,2007-12-06 17:09:03,2007-12-04,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.98,"+1,812","73,643",+3%,"+$16,275",-5,+8,-3,-13
390,,2007-12-06 17:07:37,2007-12-04,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.98,"+57,303","3,605,684",+2%,"+$514,684",-5,+8,-3,-13
391,,2007-12-06 17:06:33,2007-12-04,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.98,+153,"277,072",0%,"+$1,374",-5,+8,-3,-13
392,M,2007-12-03 18:56:30,2007-11-29,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.68,"+17,130","2,307,574",+1%,"+$148,697",+5,+2,+12,-8
393,M,2007-12-03 18:51:30,2007-11-29,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.68,"+3,043","71,831",+4%,"+$26,415",+5,+2,+12,-8
394,M,2007-12-03 18:47:00,2007-11-29,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.68,"+96,313","3,548,381",+3%,"+$836,043",+5,+2,+12,-8
395,M,2007-12-03 18:40:31,2007-11-29,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.68,+258,"276,919",0%,"+$2,240",+5,+2,+12,-8
396,M,2007-11-28 17:31:01,2007-11-26,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.11,"+1,102","276,661",0%,"+$8,936",+2,+12,+22,+18
397,M,2007-11-28 17:24:02,2007-11-26,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.11,"+73,260","2,290,444",+3%,"+$594,060",+2,+12,+22,+18
398,M,2007-11-28 17:19:32,2007-11-26,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.11,"+411,940","3,452,068",+14%,"+$3,340,392",+2,+12,+22,+18
399,M,2007-11-28 17:14:29,2007-11-26,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.11,"+13,019","68,788",+23%,"+$105,570",+2,+12,+22,+18
400,M,2007-11-21 17:05:20,2007-11-19,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.18,"+70,742","2,217,184",+3%,"+$579,009",+1,+4,+32,+22
401,M,2007-11-21 17:04:24,2007-11-19,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.17,"+278,911","3,040,128",+10%,"+$2,278,239",+1,+4,+32,+22
402,M,2007-11-21 16:58:24,2007-11-19,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.17,"+8,814","55,769",+19%,"+$71,996",+1,+4,+32,+22
403,M,2007-11-21 16:55:51,2007-11-19,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.17,+747,"275,559",0%,"+$6,102",+1,+4,+32,+22
404,,2007-11-21 16:52:50,2007-11-19,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.22,+318,"89,874",0%,"+$2,615",+1,+4,+32,+22
405,M,2007-11-16 17:41:21,2007-11-14,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.49,"+10,664","46,955",+29%,"+$90,538",-3,-2,+26,+23
406,M,2007-11-16 17:40:23,2007-11-14,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.49,"+337,456","2,761,217",+14%,"+$2,865,032",-3,-2,+26,+23
407,M,2007-11-16 17:39:21,2007-11-14,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.50,"+126,099","2,146,442",+6%,"+$1,071,955",-3,-2,+26,+23
408,M,2007-11-16 17:38:26,2007-11-14,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.49,+904,"274,812",0%,"+$7,675",-3,-2,+26,+23
409,AM,2007-11-16 16:24:18,2007-11-14,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.51,"+1,053","89,556",+1%,"+$8,965",-3,-2,+26,+23
410,M,2007-11-13 17:45:21,2007-11-09,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.09,"+2,442","88,503",+3%,"+$19,746",+2,-3,+25,+22
411,M,2007-11-13 17:42:15,2007-11-09,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.09,"+21,926","36,291",+153%,"+$177,292",+2,-3,+25,+22
412,M,2007-11-13 17:40:26,2007-11-09,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.09,"+274,182","3,998,325",+7%,"+$2,217,012",+2,-3,+25,+22
413,M,2007-11-13 17:38:16,2007-11-09,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.09,"+693,773","2,423,761",+40%,"+$5,609,789",+2,-3,+25,+22
414,M,2007-11-13 17:35:50,2007-11-09,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.09,"+1,857","273,908",+1%,"+$15,016",+2,-3,+25,+22
415,,2007-08-20 16:10:07,2007-08-17,INCY,Friedman Paul A,CEO,P - Purchase,$5.47,"+16,665","191,565",+10%,"+$91,159",+5,+5,+16,+116
416,M,2007-08-03 17:36:54,2007-08-01,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$4.91,"+171,332","1,746,161",+11%,"+$840,554",+11,+5,+21,+151
417,M,2007-08-03 17:35:49,2007-08-01,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$4.91,"+451,861","1,729,988",+35%,"+$2,216,827",+11,+5,+21,+151
418,M,2007-08-03 17:34:53,2007-08-01,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$4.91,"+1,151","272,051",0%,"+$5,647",+11,+5,+21,+151
419,M,2007-08-03 17:33:50,2007-08-01,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$4.91,"+14,365","14,365",New,"+$70,475",+11,+5,+21,+151
420,D,2007-02-13 19:01:00,2006-04-17,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,P - Purchase,$3.88,"+5,000","32,906",+18%,"+$19,416",0,-2,-13,-30
421,,2006-04-07 08:23:09,2006-04-06,INCY,Swain Paula J,"EVP, HR",P - Purchase,$3.65,"+3,000","18,061",+20%,"+$10,950",+2,+4,+14,+16
422,,2006-04-05 08:25:53,2006-04-04,INCY,Friedman Paul A,CEO,P - Purchase,$3.56,"+5,500","174,900",+3%,"+$19,580",+6,+3,+17,+15
423,,2006-04-05 08:25:34,2006-04-04,INCY,Hastings David C,CFO,P - Purchase,$3.60,"+2,500","2,500",New,"+$9,000",+6,+3,+17,+15
424,,2006-04-05 08:25:21,2006-04-04,INCY,Schreck Patricia A,"EVP, GC",P - Purchase,$3.59,"+2,000","2,000",New,"+$7,180",+6,+3,+17,+15
425,,2005-08-23 15:20:16,2005-08-23,INCY,Friedman Paul A,CEO,P - Purchase,$7.24,"+2,700","119,400",+2%,"+$19,559",0,+5,+2,-22
426,,2005-03-10 15:27:28,2005-03-09,INCY,De Schutter Richard U,Dir,P - Purchase,$7.05,"+20,000","25,000",+400%,"+$140,950",0,+1,-5,+8
427,,2004-11-04 16:08:55,2004-11-01,INCY,Baker Julian,Dir,P - Purchase,$9.75,"+300,000","209,948",-333%,"+$2,925,000",+6,+12,+20,-11
428,,2004-09-13 18:33:35,2004-09-09,INCY,Brooke Paul A,Dir,P - Purchase,$7.74,"+100,000","149,584",+202%,"+$774,000",+3,+2,+22,-10
429,,2004-08-17 16:34:54,2004-08-16,INCY,Friedman Paul A,CEO,P - Purchase,$5.62,"+3,500","421,135",+1%,"+$19,658",+6,+8,+50,+48
430,A,2004-08-13 15:58:35,2004-08-12,INCY,Tisch Thomas J,No longer 10% owner.,P - Purchase,$5.50,"+255,750","1,534,253",+20%,"+$1,406,625",+1,+15,+55,+56
431,A,2004-08-13 15:58:06,2004-08-12,INCY,Tisch James S,No longer 10% owner.,P - Purchase,$5.50,"+255,750","1,334,253",+24%,"+$1,406,625",+1,+15,+55,+56
432,A,2004-08-13 15:57:37,2004-08-12,INCY,Tisch Andrew H,No longer 10% owner.,P - Purchase,$5.50,"+255,750","1,334,253",+24%,"+$1,406,625",+1,+15,+55,+56
433,A,2004-08-13 15:57:05,2004-08-12,INCY,Tisch Daniel R,No longer 10% owner.,P - Purchase,$5.50,"+255,750","1,334,253",+24%,"+$1,406,625",+1,+15,+55,+56
434,,2004-08-13 13:23:28,2004-08-12,INCY,Tisch Daniel R,10%,P - Purchase,$5.50,"+255,750","1,334,253",+24%,"+$1,406,625",+1,+15,+55,+56
435,,2004-08-13 13:22:36,2004-08-12,INCY,Tisch Andrew H,10%,P - Purchase,$5.50,"+255,750","1,334,253",+24%,"+$1,406,625",+1,+15,+55,+56
436,,2004-08-13 13:21:50,2004-08-12,INCY,Tisch James S,10%,P - Purchase,$5.50,"+255,750","1,334,253",+24%,"+$1,406,625",+1,+15,+55,+56
437,,2004-08-13 13:20:59,2004-08-12,INCY,Tisch Thomas J,10%,P - Purchase,$5.50,"+255,750","1,534,253",+20%,"+$1,406,625",+1,+15,+55,+56
438,,2003-09-24 17:22:50,2003-09-22,INCY,Baker Bros Capital Gp LLC,10%,P - Purchase,$4.97,"+13,800","526,800",+3%,"+$68,592",-8,-12,+1,+48
439,,2003-09-24 17:22:37,2003-09-22,INCY,Baker Biotech Capital II Gp LLC,10%,P - Purchase,$4.97,"+71,100","2,181,814",+3%,"+$353,399",-8,-12,+1,+48
440,,2003-09-24 17:22:26,2003-09-22,INCY,Baker Biotech Capital Gp LLC,10%,P - Purchase,$4.97,"+67,300","2,959,310",+2%,"+$334,507",-8,-12,+1,+48
441,,2003-09-23 17:18:43,2003-09-19,INCY,Baker Bros Capital Gp LLC,10%,P - Purchase,$5.04,"+107,650","249,700",+76%,"+$542,276",+6,-3,+10,+60
442,,2003-09-23 17:18:30,2003-09-19,INCY,Baker Biotech Capital Gp LLC,10%,P - Purchase,$5.04,"+526,000","1,412,855",+59%,"+$2,649,672",+6,-3,+10,+60
443,,2003-09-23 17:18:15,2003-09-19,INCY,Baker Biotech Capital II Gp LLC,10%,P - Purchase,$5.04,"+556,350","1,020,307",+120%,"+$2,802,557",+6,-3,+10,+60
